← Russell 3000 cross-section

AVAH Aveanna Healthcare Holdings, Inc.

Trailing twelve months to 2026-07-04 · as filed 2026-08-13, not restated
Healthcare

Scale

Market cap
$3.0bn
Revenue TTM
$2.6bn
Net income TTM
$275m
Free cash flow
Composite score
57.5
Sector rank
#1408

Valuation

P / E
10.8
EV / EBITDA
EV / sales
1.6
FCF yield
Earnings yield vs 10-yr
4.53pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
10.6%
EBITDA margin
ROE
95.6%
ROIC
18.6%
Revenue growth
19.5%

Insider activity, last 90 days

Net open-market
$-773.12m
Buyers
0
Sellers
6

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Management tracks home health revenue per completed episode over time to evaluate both the clinical and financial profile of the business in a single metric. Results of Operations Three-Month Period Ended July 4, 2026 Compared to the Three-Month Period Ended June 28, 2025 The following table summarizes our consolidated results of operations, including Field contribution, which is a non-GAAP measure (see “Non-GAAP Financial Measures” below), for the three-month periods indicated: NM = A percentage calculation that is not meaningful due to a percentage change greater than 1000% . …Aveanna Healthcare Holdings, Inc., 10-Q, period ended 2026-07-04, filed 2026-08-13

Read the full passage →